We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.01%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYNT
15376
DELISTED
Dynatronics Corp
DYNT
-10,722
Closed -$16.1K
CSSE
15377
CALL
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
-10,532
Closed -$21.1K
CSSE
15378
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
-42,230
Closed -$84.5K
CSSE
15379
PUT
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
-1,300
Closed -$2.6K
EFTRW
15380
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
-27,743
Closed -$3.58K
AKLI
15381
CALL
DELISTED
Akili Inc
AKLI
-10,300
Closed -$16.5K
AKLI
15382
PUT
DELISTED
Akili Inc
AKLI
-3,300
Closed -$5.28K
FNCB
15383
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
-11,334
Closed -$70.3K
TCON
15384
CALL
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-1,235
Closed -$46.7K
TCON
15385
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-999
Closed -$37.8K
TCON
15386
PUT
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-145
Closed -$5.48K
FBGX
15387
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
-3,676
Closed -$1.77M
SCPX
15388
DELISTED
Scorpius Holdings, Inc.
SCPX
-12
Closed -$34.4K
CACG
15389
DELISTED
Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF
CACG
-16,979
Closed -$640K
DCPH
15390
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-13,900
Closed -$215K
DCPH
15391
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-146,211
Closed -$2.26M
DCPH
15392
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-12,800
Closed -$198K
AVGR
15393
DELISTED
Avinger, Inc. Common Stock
AVGR
-4,382
Closed -$52.6K
ENG
15394
CALL
DELISTED
ENGlobal Corp
ENG
-675
Closed -$2.59K
LBAI
15395
CALL
DELISTED
Lakeland Bancorp Inc
LBAI
-2,800
Closed -$43.8K
OPGN
15396
DELISTED
OpGen, Inc
OPGN
-1,396
Closed -$18.6K
GENE
15397
CALL
DELISTED
Genetic Technologies Ltd.
GENE
-1,580
Closed -$9.24K
GENE
15398
DELISTED
Genetic Technologies Ltd.
GENE
-242
Closed -$1.41K
GENE
15399
PUT
DELISTED
Genetic Technologies Ltd.
GENE
-240
Closed -$1.4K
TRVN
15400
DELISTED
Trevena, Inc.
TRVN
-4
Closed -$98

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.